Glenmark Pharma zooms 10% on positive management commentary
Glenmark Pharma aims to turn cash positive by the end of the current fiscal. The drugmaker also expects respiratory and injectables to be the major contributors in FY25
Stay updated with breaking news from Uzzing Stocks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Glenmark Pharma aims to turn cash positive by the end of the current fiscal. The drugmaker also expects respiratory and injectables to be the major contributors in FY25
In the past year, Nifty surged 22%, So far 2024 BSE PSU gains reached 18%, outpacing Nifty's 0.4%. The year 2023 saw PSU gains of 55.3%, while Nifty jumped 20%.
Out of 40 mutual funds invested in HDFC Bank, 27 stepped up their holdings in January, while 13 chose to dilute part of their stakes. ICICI Prudential MF led the buyers with the highest purchase of Rs 3,933 crore
In the past year, Nifty surged 22%, So far 2024 BSE PSU gains reached 18%, outpacing Nifty's 0.4%. The year 2023 saw PSU gains of 55.3%, while Nifty jumped 20%.
It took the company 12 years to reach Rs 10 lakh crore in 2017 from Rs 1 lakh crore in 2005 and five more years to double to Rs 20 lakh crore.